| Title |
The use of metformin in type 1 diabetes: a systematic review of efficacy
|
|---|---|
| Published in |
Diabetologia, January 2010
|
| DOI | 10.1007/s00125-009-1636-9 |
| Pubmed ID | |
| Authors |
S. Vella, L. Buetow, P. Royle, S. Livingstone, H. M. Colhoun, J. R. Petrie |
| Abstract |
As adding metformin to insulin therapy has been advocated in type 1 diabetes, we conducted a systematic review of published clinical trials and clinical trial databases to assess the effects on HbA(1c), weight, insulin-dose requirement and adverse effects. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Argentina | 1 | 33% |
| Spain | 1 | 33% |
| United States | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 188 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 2% |
| United States | 2 | 1% |
| Brazil | 2 | 1% |
| Unknown | 181 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 23 | 12% |
| Other | 22 | 12% |
| Student > Bachelor | 20 | 11% |
| Student > Ph. D. Student | 19 | 10% |
| Researcher | 16 | 9% |
| Other | 48 | 26% |
| Unknown | 40 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 80 | 43% |
| Agricultural and Biological Sciences | 12 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 5% |
| Biochemistry, Genetics and Molecular Biology | 9 | 5% |
| Nursing and Health Professions | 8 | 4% |
| Other | 23 | 12% |
| Unknown | 46 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2023.
All research outputs
#1,576,279
of 24,792,414 outputs
Outputs from Diabetologia
#857
of 5,301 outputs
Outputs of similar age
#6,951
of 174,419 outputs
Outputs of similar age from Diabetologia
#2
of 29 outputs
Altmetric has tracked 24,792,414 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,301 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.4. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,419 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.